Announced Mon, 27 Jul · 15:57 IST
Bajaj Healthcare Q1 FY27 Earnings Call Transcript
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Bajaj Healthcare Q1 FY27 earnings call transcript. Revenue rose 11.3% YoY to INR165.6 crores, EBITDA margin 17.8% (up 70 bps), PAT INR13.9 crores. Management guided 10-15% revenue growth and 18-20% EBITDA margins for FY27/FY28. Long-term revenue target of INR900-1,000 crores in 2-3 years. Peptide plant to commission Q4 FY27 with potential peak revenue of INR200-300 crores. D/E ratio improved to 0.45 from 1.19.
Likely market impact
Positive signals with margin expansion guidance, deleveraging, and growth visibility in peptides and oncology. 2-3 year revenue target of INR900-1,000 crores.